Trevi Therapeutics (TRVI) PT Raised to $11 at B.Riley
Tweet Send to a Friend
(Updated - January 8, 2025 7:36 AM EST)
B.Riley analyst Mayank Mamtani raised the price target on Trevi Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
B.Riley analyst Mayank Mamtani raised the price target on Trevi Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
